There are chances this counter trend rally may extend towards 9,400-9,600 zone. However, we would advise the traders to exercise caution at higher levels. Stocks in news: Gujarat Alkalies & Chemicals, Transgene Biotek, Camlin Fine Sciences, Cadila Healthcare, Lasa Supergenerics.

Welcome to Dalal Street after a long weekend. Today, Indian markets will be back to work.  The beginning of the week seems to be a tepid one as the early indications by SGX Nifty show that markets are set for an insipid start. SGX Nifty trades down by 50 points at 9,056 levels.

Punjab & Sind Bank announced that its board is planning to raise equity capital next week via QIP and preferential issue.

Natural gas distribution company, Adani Gas Limited, gained more than two per cent after the company reduced prices of compressed natural gas (CNG) as well as piped natural gas (PNG).

The shares of world’s seventh largest tyre manufacturer, Apollo Tyres Ltd jumped nearly eight per cent on April 9, after the company announced that it has raised Rs 500 crore through NCDs.

Larsen & Toubro (L&T) has come up with new innovative technologies such as artificial intelligence to help the local authorities in monitoring and implementing measures to combat the spread of COVID-19.

New Fund Offers (NFOs) that are open for subscription.

Zydus Cadila announced that the company has received a final approval from US Food & Drug Administration (USFDA) to market Imatinib Mesylate tablets, 100 mg and 400 mg.

Despite all the fall in the equity market, investors have shown faith in equity as an asset class and poured in Rs 30,109 crore in equity dedicated funds in the month of March 2020.

The key reason for this staggered performance was the lack of any strong trigger that could bring certainty in term of revenue. Further, many regulatory hurdles, such as from USFDA, also made things difficult for these companies.